Home » Topics » Patents, BioWorld Science

Patents, BioWorld Science
RSS

New melanocortin receptor modulators presented by Palatin Technologies

Sep. 2, 2021

Newave Pharmaceutical presents quinuclidinone analogues

Sep. 2, 2021

Cytokinetics synthesizes new Nampt activators

Sep. 2, 2021

Nimbus Iaso patents IRE1-targeting compounds

Sep. 2, 2021

Kymera Therapeutics describes new PROTACs for inflammatory disorders

Sep. 2, 2021

Rockefeller University presents new LATS1 inhibitors

Sep. 1, 2021

Japanese researchers synthesize new PROTACs for cancer

Sep. 1, 2021

Arbutus Biopharma identifies PD-L1 antagonists

Sep. 1, 2021

Fileclo Sp zoo discloses new compounds for cancer

Sep. 1, 2021

Eternity Bioscience patents new ADAMTS inhibitors

Sep. 1, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...